BeGraft Coronary Stent Graft System - Mesh-sleeve coronary artery stent

País: Australia

Idioma: inglés

Fuente: Department of Health (Therapeutic Goods Administration)

Disponible desde:

Device Technologies Australia Pty Ltd

clase:

Class III

Fabricado por:

Bentley InnoMed GmbH Lotzenacker 3, Hechingen, 72379 Germany

Área terapéutica:

57788 - Mesh-sleeve coronary artery stent

indicaciones terapéuticas:

The BeGraft Coronary Stent Graft System consists of: - a balloon-expandable cobalt-chromium (L605) stent, covered with an ePTFE graft material, which is - pre-mounted on the balloon of a rapid exchange (RX)stent delivery system. The delivery system is compatible with 0.014? guide wires and is available in usable lengths of 143 cm and 153 cm. The BeGraft Coronary Stent Graft System is indicated for transluminal implantation in coronary arteries or aorto-coronary bypass grafts for the treatment of: 1. Acute perforation or rupture of coronary arteries. 2. Aneurysm of coronary arteries or coronary bypass-vein graft.

Estado de Autorización:

A

Fecha de autorización:

2016-08-03